280,000+ Strain Resource Bank: Wecare’s Irreplaceable Genetic Core Asset

Introduction

Strain resource reserves determine the upper limit of microbial enterprise R&D capacity, yet most global probiotic manufacturers hold less than 50,000 preserved strains (MIT Technology Review, 2024, https://www.technologyreview.com). Wecare built China’s top-tier probiotic strain and genetic resource bank with 280,000 independent strains, supporting full-chain customized strain development for global industrial clients.

Main Body

The strain library is split into two core categories: 120,000 human-origin strains isolated from infant intestines, maternal tracts and oral cavities, and 160,000 agricultural-origin strains extracted from plant rhizosphere, livestock intestines and natural soil (Wecare Strain Resource Manual,2026, Wecare-Bio official website). Over 80,000 strains have finished whole-genome sequencing, forming a retrievable global genomic database with 35,000 annotated gene entries. Wecare’s AI intelligent strain management system supports automatic colony imaging, low-temperature smart storage and one-click strain retrieval, cutting manual screening time by 70%. A US functional food brand cooperation case: the client needed triple composite probiotics for weight management. Wecare’s genomic database matched 17 candidate strains within 1 day, and AI predicted metabolic efficacy, completing strain combination verification in only 3 weeks. Academician Chen Wei, chairman of the Probiotics Industry Technology Innovation Strategic Alliance, stated that large standardized strain banks are the industrial foundation for microbiome commercialization (Chinese Society of Food Science and Technology, 2026 Industry White Paper). Wecare opens strain screening, gene sequencing and customized strain development services to global food, agriculture and biopharmaceutical enterprises.

Conclusion

Massive, classified, fully sequenced strain genetic resources form Wecare’s non-replicable core asset. Combined with AI intelligent screening technology, the strain bank drastically reduces independent R&D time and cost for downstream manufacturers worldwide, building a long-term industrial competitive barrier.